{"id":"https://openalex.org/W7120538899","doi":null,"title":"Reposicionamento de f\u00e1rmacos no tratamento da esquizofrenia: um estudo duplo-cego, randomizado, de \u00e1cido alfa-lipoico em baixas doses","display_name":"Reposicionamento de f\u00e1rmacos no tratamento da esquizofrenia: um estudo duplo-cego, randomizado, de \u00e1cido alfa-lipoico em baixas doses","publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W7120538899"},"language":"pt","primary_location":{"id":"pmh:oai:repositorio.ufc.br:riufc/76487","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.ufc.br/handle/riufc/76487","pdf_url":"http://repositorio.ufc.br/bitstream/riufc/76487/1/2024_dis_ijfrota.pdf","source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"instacron:UFC","raw_type":"info:eu-repo/semantics/masterThesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://repositorio.ufc.br/bitstream/riufc/76487/1/2024_dis_ijfrota.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087102445","display_name":"Ilgner Justa Frota","orcid":"https://orcid.org/0000-0002-4362-3916","observed_orcids":["https://orcid.org/0000-0002-4362-3916"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Frota, Ilgner Justa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5087102445"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12915","display_name":"Biochemical Acid Research Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9279999732971191},{"id":"https://openalex.org/keywords/alpha-lipoic-acid","display_name":"alpha-lipoic acid","score":0.9980000257492065},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.8849999904632568},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.7799999713897705},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.5170000195503235},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.6460000276565552},{"id":"https://openalex.org/keywords/placebo-effect","display_name":"placebo effect","score":0.6570000052452087},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.6600000262260437},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9869999885559082}],"concepts":[{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.72079998254776},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7059999704360962},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6654999852180481},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.5932000279426575},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5353000164031982},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5293999910354614},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5264000296592712},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.5095000267028809},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.44449999928474426},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.43209999799728394},{"id":"https://openalex.org/C2778528637","wikidata":"https://www.wikidata.org/wiki/Q4967025","display_name":"Brief Psychiatric Rating Scale","level":3,"score":0.4253000020980835},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.40290001034736633},{"id":"https://openalex.org/C14216870","wikidata":"https://www.wikidata.org/wiki/Q3872","display_name":"Neuropsychology","level":3,"score":0.38690000772476196},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3765999972820282},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.32739999890327454},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.32710000872612},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3061000108718872},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.2946999967098236},{"id":"https://openalex.org/C2776244919","wikidata":"https://www.wikidata.org/wiki/Q2419446","display_name":"Management of schizophrenia","level":4,"score":0.2858999967575073},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.2816999852657318},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.27649998664855957},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.2712000012397766},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.26589998602867126},{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.2556999921798706},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2500999867916107}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:repositorio.ufc.br:riufc/76487","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.ufc.br/handle/riufc/76487","pdf_url":"http://repositorio.ufc.br/bitstream/riufc/76487/1/2024_dis_ijfrota.pdf","source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"instacron:UFC","raw_type":"info:eu-repo/semantics/masterThesis"}],"best_oa_location":{"id":"pmh:oai:repositorio.ufc.br:riufc/76487","doi":null,"is_oa":true,"landing_page_url":"http://repositorio.ufc.br/handle/riufc/76487","pdf_url":"http://repositorio.ufc.br/bitstream/riufc/76487/1/2024_dis_ijfrota.pdf","source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"instacron:UFC","raw_type":"info:eu-repo/semantics/masterThesis"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7120538899.pdf","grobid_xml":"https://content.openalex.org/works/W7120538899.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W2911452443"],"related_works":["https://openalex.org/W4313304390","https://openalex.org/W7120462261","https://openalex.org/W4294917579","https://openalex.org/W4386484289","https://openalex.org/W7171939277","https://openalex.org/W4283695404","https://openalex.org/W2188990519","https://openalex.org/W2103507060","https://openalex.org/W4353015890","https://openalex.org/W2131417790"],"abstract_inverted_index":{"Schizophrenia":[0],"can":[1],"be":[2,139],"a":[3,40,59,66,98,158,173,275,286],"very":[4],"impairing":[5],"mental":[6],"disorder,":[7],"mainly":[8],"due":[9],"to":[10,45,104,122,134,192,254,329],"the":[11,20,46,53,80,95,106,123,148,166,181,222,250,255,259,290],"intellectual,":[12],"interpersonal,":[13],"emotional,":[14],"and":[15,65,143,172,183,202,208,218,247,265,301,312],"social":[16],"impairments":[17],"that":[18,56,320],"encompass":[19],"so-called":[21],"negative":[22,50,83,142],"symptoms.":[23,51],"However,":[24,258],"even":[25],"though":[26],"treatment":[27,115,184],"with":[28,43,75,111,116,178,331],"dopamine":[29],"D2":[30],"receptor":[31],"blockers":[32],"is":[33,39,58,323],"effective":[34],"for":[35,79,128],"psychotic":[36],"symptoms,":[37,145,163],"there":[38,57,137],"clinical":[41,107,235],"gap":[42],"regard":[44],"pharmacological":[47],"management":[48],"of":[49,62,69,82,97,109,126,175,213,237,244,262],"Given":[52],"preclinical":[54],"evidence":[55],"low":[60],"level":[61,68],"endogenous":[63],"antioxidants":[64],"high":[67],"reactive":[70],"oxygen":[71],"species":[72],"in":[73,230,249,271,279,289,305],"patients":[74,110,263,330],"schizophrenia,":[76,238],"several":[77,272],"drugs":[78],"relief":[81],"symptoms":[84,236],"have":[85],"been":[86],"investigated":[87],"under":[88],"this":[89,280],"theoretical":[90],"basis.":[91],"Here":[92],"we":[93],"report":[94],"results":[96],"randomized,":[99],"double-blind,":[100],"placebo-controlled":[101],"translational":[102],"study":[103,223],"evaluate":[105,135],"response":[108],"schizophrenia":[112],"receiving":[113],"adjuvant":[114,124],"alpha-lipoic":[117,291,327],"acid":[118,292,328],"100":[119],"mg/day,":[120],"compared":[121,253],"use":[125],"placebo,":[127],"sixteen":[129],"weeks.":[130],"Our":[131],"goal":[132],"was":[133,285],"whether":[136],"would":[138],"changes":[140],"in:":[141],"positive":[144],"assessed":[146,164],"using":[147],"Brief":[149],"Psychiatric":[150],"Rating":[151],"Scale":[152],"(BPRS);":[153],"cognitive":[154],"functioning,":[155],"observed":[156],"through":[157],"standardized":[159],"neuropsychological":[160],"assessment;":[161],"extrapyramidal":[162],"by":[165],"Simpson-Angus":[167],"Scale;":[168],"body":[169,231],"mass":[170,232],"index;":[171],"series":[174],"oxidative/inflammatory":[176],"parameters,":[177],"comparisons":[179],"between":[180,200],"placebo":[182,256,266,277],"groups.":[185],"Continuous":[186],"antipsychotic":[187,239],"medications":[188],"were":[189,211],"maintained":[190],"according":[191],"each":[193],"patient's":[194],"usual":[195],"medical":[196],"prescription.":[197],"48":[198],"people":[199],"eighteen":[201],"sixty":[203],"years":[204],"old":[205],"(32":[206],"men":[207,217],"16":[209],"women)":[210,220],"included,":[212],"which":[214],"35":[215],"(23":[216],"12":[219],"completed":[221],"protocol.":[224],"We":[225],"found":[226],"no":[227],"significant":[228,287],"improvement":[229],"index,":[233],"cognition,":[234],"adverse":[240],"effects,":[241],"or":[242],"markers":[243],"oxidative":[245],"stress":[246],"inflammation":[248],"intervention":[251],"group":[252,261],"group.":[257],"entire":[260],"(intervention":[264],"groups,":[267],"taken":[268],"together)":[269],"improved":[270],"aspects,":[273],"indicating":[274],"strong":[276],"effect":[278],"population.":[281],"A":[282],"surprising":[283],"finding":[284],"decrease":[288,304],"treated":[293],"group\u2019s":[294],"red":[295,306],"blood":[296,299,307,310],"cells,":[297,300],"white":[298,309],"platelets.":[302],"This":[303],"cell,":[308,311],"platelet":[313],"counts":[314],"requires":[315],"further":[316],"investigation.":[317],"It":[318],"suggests":[319],"more":[321],"attention":[322],"needed":[324],"when":[325],"prescribing":[326],"schizophrenia.":[332]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-01-10T00:00:00"}